5PSQ-109 Active pharmacovigilance in oncology: pharmacological contribution to improve reports

BACKGROUND: Pharmacovigilance has intrinsic limits, for example in the hospital the main problem is associated with poor doctor reporting. In addition, reports are superficial and lacking in patient history and therapy data. In thye Oncology Department, there are many adverse drug reactions (ADRs),...

Full description

Saved in:
Bibliographic Details
Published in:Eur J Hosp Pharm
Main Authors: Beretta, FN, Zenoni, D, Bonzi, D
Format: Artigo
Language:Inglês
Published: BMJ Group 2018
Subjects:
Section 5: Patient safety and quality assurance
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535590/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.462
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items